BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11776144)

  • 21. Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats.
    Tan XD; Dou YC; Shi CW; Duan RS; Sun RP
    J Neuroimmunol; 2009 Feb; 207(1-2):39-44. PubMed ID: 19174309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
    Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
    Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase.
    Hartung HP; Schäfer B; Heininger K; Toyka KV
    Ann Neurol; 1988 May; 23(5):453-60. PubMed ID: 3260463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Jin T; Adem A; Zhu J
    Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of treatment with crotapotin on the evolution of experimental autoimmune neuritis induced in Lewis rats.
    Castro FR; Farias AS; Proença PL; de La Hoz C; Langone F; Oliveira EC; Toyama MH; Marangoni S; Santos LM
    Toxicon; 2007 Mar; 49(3):299-305. PubMed ID: 17145071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical study of caveolin-1 in the sciatic nerves of Lewis rats with experimental autoimmune neuritis.
    Ahn M; Moon C; Kim H; Lee J; Sung Koh C; Matsumoto Y; Shin T
    Brain Res; 2006 Aug; 1102(1):86-91. PubMed ID: 16806125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early changes in experimental allergic neuritis.
    Powell HC; Braheny SL; Myers RR; Rodriguez M; Lampert PW
    Lab Invest; 1983 Mar; 48(3):332-8. PubMed ID: 6338293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphatidylserine suppresses myelin-induced experimental allergic neuritis (EAN) in Lewis rats.
    Maeda Y; Maeda R; Prineas JW; Ledeen RW
    J Neuropathol Exp Neurol; 1994 Nov; 53(6):672-7. PubMed ID: 7964907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on therapy of experimental autoimmune neuritis by bone marrow stromal cells].
    Xu X; Sun B; Mu LL; Wang GY; Jin LH; Li HL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):52-5. PubMed ID: 17210108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prednisolone therapy of experimental allergic neuritis in Lewis rats does not induce relapsing or chronic disease.
    Stevens A; Schabet M; Wiethölter H; Schott K
    J Neuroimmunol; 1990 Jul; 28(2):141-51. PubMed ID: 2362015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-inflammatory and immunomodulatory potential of human immunoglobulin applied intrathecally in Lewis rat experimental autoimmune neuritis.
    Pitarokoili K; Kohle F; Motte J; Fatoba O; Pedreiturria X; Gold R; Yoon MS
    J Neuroimmunol; 2017 Aug; 309():58-67. PubMed ID: 28601289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat.
    Enders U; Toyka KV; Hartung HP; Gold R
    J Neuroimmunol; 1997 Jun; 76(1-2):112-6. PubMed ID: 9184640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide.
    Bechtold DA; Yue X; Evans RM; Davies M; Gregson NA; Smith KJ
    Brain; 2005 Jan; 128(Pt 1):18-28. PubMed ID: 15509620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of associated cell-mediated immune mechanisms in experimental autoimmune neuritis rats.
    Yun W; Hua-bing W; Wei-zhi W
    J Neuroimmunol; 2007 Apr; 185(1-2):87-94. PubMed ID: 17346805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis.
    Zhang ZY; Zhang Z; Schluesener HJ
    Neuropathol Appl Neurobiol; 2009 Oct; 35(5):487-95. PubMed ID: 19207263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
    Nicoletti F; Créange A; Orlikowski D; Bolgert F; Mangano K; Metz C; Di Marco R; Al Abed Y
    J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of experimental allergic neuritis with prednisolone.
    Feasby TE; Gilbert JJ; Hahn AF; Lovgren DS
    Can J Neurol Sci; 1987 Feb; 14(1):46-9. PubMed ID: 3493057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
    Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
    J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.